Runhua Liu

Title: Innovations in Cancer Treatment by Runhua Liu

Introduction

Runhua Liu is an accomplished inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on the role of FOXP3 in tumor suppression, which has the potential to advance therapeutic strategies for cancer patients.

Latest Patents

Runhua Liu holds a patent for "Materials and methods for FOXP3 tumor suppression." This patent outlines methods for treating cancer by administering a FOXP3 protein, a nucleic acid encoding a FOXP3 protein, or an inducing compound that promotes FOXP3 protein expression. The patent also describes techniques for altering the phenotype of cancer cells, inhibiting their growth, and inducing apoptosis. Additionally, diagnostic methods are provided to compare FOXP3 protein or gene expression in test samples against normal or prior samples. The patent further includes a method for screening test compounds for anti-cancer activity by measuring FOXP3 expression.

Career Highlights

Runhua Liu is affiliated with the University of Michigan, where he conducts his research and develops his innovative methods. His work has garnered attention for its potential impact on cancer therapies, making him a notable figure in the field of biomedical research.

Collaborations

Runhua Liu collaborates with esteemed colleagues, including Yang Liu and Pan Zheng, who contribute to his research endeavors. Their combined expertise enhances the development of effective cancer treatment strategies.

Conclusion

Runhua Liu's innovative work in cancer treatment through the exploration of FOXP3 protein mechanisms represents a significant advancement in the field. His patented methods and ongoing research hold promise for improving therapeutic options for cancer patients.